Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tuberculosis, Multidrug Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT05493267
What this trial is testing

A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB

Who this might be right for
MDR-TBImmunotherapy
Shanghai Pulmonary Hospital, Shanghai, China 30
Testing effectiveness (Phase 2)Study completedNCT00910871
What this trial is testing

To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA 241
Post-approval studies (Phase 4)Study completedNCT03830671
What this trial is testing

The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB

Who this might be right for
Multi-drug Resistant Tuberculosis
Beijing Chest Hospital 515
Not applicableLooking for participantsNCT05633056
What this trial is testing

An Adaptive Randomized Controlled Trial

Who this might be right for
Multi Drug Resistant TuberculosisHIV Infections
Columbia University 360
Not applicableStudy completedNCT01618422
What this trial is testing

Directly Observed Therapy Short Course-Plus Versus DOTS for Retreatment of Relapsed Pulmonary Tuberculosis in Guangzhou

Who this might be right for
Pulmonary Tuberculosis
Chinese University of Hong Kong 225
Large-scale testing (Phase 3)Study completedNCT03338621
What this trial is testing

Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+2 more
Global Alliance for TB Drug Development 455
Testing effectiveness (Phase 2)Study completedNCT04179500
What this trial is testing

A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+2 more
Global Alliance for TB Drug Development 26
Not applicableUnknownNCT05871489
What this trial is testing

Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens

Who this might be right for
Tuberculosis, Multidrug-ResistantHIV
Harvard Medical School (HMS and HSDM) 800
Not applicableStudy completedNCT03942354
What this trial is testing

Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial

Who this might be right for
Multidrug Resistant Tuberculosis
Medecins Sans Frontieres, Netherlands 137
Not applicableNot Yet RecruitingNCT06700577
What this trial is testing

Multidrug Resistance in Newly Diagnosed TB Patient

Who this might be right for
Tuberculosis
Assiut University 100
Not applicableStudy completedNCT04342598
What this trial is testing

Case Control Study of Vitamin D Status and Adult Multidrug-resistant Pulmonary Tuberculosis in Maharashtra, India

Who this might be right for
Multi-drug Resistant Tuberculosis
Harvard School of Public Health (HSPH) 352
Post-approval studies (Phase 4)Study completedNCT01521364
What this trial is testing

Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients

Who this might be right for
Multidrug-resistant TuberculosisExtensively Drug-resistant Tuberculosis
University Medical Center Groningen 7
Not applicableStudy completedNCT02597621
What this trial is testing

Biomarkers for Therapy Response in Drug-resistant Tuberculosis

Who this might be right for
Tuberculosis, Multidrug-resistant
Research Center Borstel 192
Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Large-scale testing (Phase 3)Study completedNCT01977768
What this trial is testing

TB Immunotherapy Trial With Heat-killed M. Vaccae

Who this might be right for
Tuberculosis
Immunitor LLC 152
Not applicableUnknownNCT04484129
What this trial is testing

MDR-TB Close Contacts Tracing in China (TCCT Study)

Who this might be right for
Multidrug Resistant Tuberculosis
Huashan Hospital 500
Early research (Phase 1)Study completedNCT01856634
What this trial is testing

Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis

Who this might be right for
Multidrug Resistant TuberculosisPediatric
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07393438
What this trial is testing

Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS)

Who this might be right for
Multidrug-Resistant TuberculosisRifampicin-resistant TuberculosisMDR-TB+1 more
Shanghai Pulmonary Hospital, Shanghai, China 120
Post-approval studies (Phase 4)UnknownNCT05306223
What this trial is testing

An Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China

Who this might be right for
Tuberculosis, Multidrug-Resistant
Beijing Chest Hospital 212
Not applicableStudy completedNCT04239326
What this trial is testing

Clinical Evaluation of tNGS for Diagnosis of DR-TB

Who this might be right for
Tuberculosis, Multidrug-Resistant
Foundation for Innovative New Diagnostics, Switzerland 800
Next Page